Journal article
Efficacy of Antiplatelet Therapy in Secondary Prevention Following Lacunar Stroke
Abstract
BACKGROUND AND PURPOSE: Lacunar stroke accounts for ≈25% of ischemic stroke, but optimal antiplatelet regimen to prevent stroke recurrence remains unclear. We aimed to evaluate the efficacy of antiplatelet agents in secondary stroke prevention after a lacunar stroke.
METHODS: We searched MEDLINE, Embase, and the Cochrane library for randomized controlled trials that reported risk of recurrent stroke or death with antiplatelet therapy in …
Authors
Kwok CS; Shoamanesh A; Copley HC; Myint PK; Loke YK; Benavente OR
Journal
Stroke, Vol. 46, No. 4, pp. 1014–1023
Publisher
Wolters Kluwer
Publication Date
April 2015
DOI
10.1161/strokeaha.114.008422
ISSN
0039-2499